home / stock / nspr / nspr news

NSPR News and Press, InspireMD Inc. From 06/10/20

Stock Information
Company Name: InspireMD Inc.
Stock Symbol: NSPR
Market: NASDAQ
Website: inspiremd.com
Menu
NSPR NSPR Quote NSPR Short NSPR News NSPR Articles NSPR Message Board
Get NSPR Alerts

News, Short Squeeze, Breakout and More Instantly...
NSPR - InspireMD Announces Publication of 12-Month Results of CGuard(TM) EPS PARADIGM Trial in EuroIntervention

Results indicate that 12 months after carotid intervention the CGuard EPS MicroNET-covered stent delivers sustained protection against postprocedural neurologic events TEL AVIV, Israel, June 10, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard...
NSPR - InspireMD, Inc. Announces Underwriter Exercise of Over-Allotment Option in Full and Closing of $11.5 Million Follow-On Underwritten Public Offering

TEL AVIV, Israel, June 08, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today the closing, on June 5, 2020, of its $11.5 milli...

NSPR - InspireMD plummets 39% after pricing $10M public offering

InspireMD (NYSEMKT: NSPR ) has priced its public offering of 22,222,200 units at $0.45/unit for expected gross proceeds of ~$10M. More news on: InspireMD, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

NSPR - InspireMD, Inc. Announces Pricing of $10 Million Underwritten Public Offering

TEL AVIV, Israel, June 03, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced the pricing of an underwritten public offering of 22,...
NSPR - InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q1 2020 Results - Earnings Call Transcript

InspireMD, Inc. (NSPR) Q1 2020 Earnings Conference Call May 12, 2020 08:30 AM ET Company Participants Jeremy Feffer - Investor Relations Marvin Slosman - Chief Executive Officer Craig Shore - Chief Financial Officer Conference Call Participants Presentation Operator ...

NSPR - InspireMD beats on revenue

InspireMD (NYSEMKT: NSPR ): Q1 GAAP EPS of -$0.43. More news on: InspireMD, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

NSPR - InspireMD Announces First Quarter 2020 Financial Results

First quarter revenue growth driven by continued strong uptake of the CGuard ™ Embolic Prevention System (EPS) in the company’s major markets Management to host investor conference call today, May 12, at 8:30am ET TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) -- Ins...
NSPR - InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12

TEL AVIV, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that management will host a conference call and webcast on...

NSPR - InspireMD's (NSPR) CEO Marvin Slosman on Q4 2019 Results - Earnings Call Transcript

InspireMD, Inc. (NSPR) Q4 2019 Earnings Conference Call March 10, 2020 08:30 AM ET Company Participants Jeremy Feffer – Investor Relations Marvin Slosman – Chief Executive Officer Craig Shore – Chief Financial Officer Conference Call Participants Vernon...

NSPR - InspireMD Announces Fourth Quarter and Year-End 2019 Financial Results

Robust CGuard™ EPS year-over-year revenue growth of 31% Management to host investor conference call today, March 10, at 8:30am ET TEL AVIV, Israel, March 10, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention...
Previous 10 Next 10